13 November 2017 EDENCRETE® AUSTRALIAN SECURITIES EXCHANGE...

13 November 2017 EDENCRETE®
AUSTRALIAN SECURITIES EXCHANGE ANNOUNCEMENT



•US UPDATE HIGHLIGHTS
New Product Development o Significant progress in development of: - A high concentration, lower cost EdenCrete®, and - A new version of EdenCrete® for use in a large new market, concrete made with pozzolanic cements, increases early / mid-term strength. - Commercial trials and sales of new versions planned in early in 2018. o NTPEP certifications of both new products to commence in early 2018. o Up to 30 commercial trials across all products scheduled in Q1 and Q2 of 2018 targeting a wide range of performance characteristics.

•SALES
Current sales target of EdenCrete® for 2017/18 is US$6 million. o Additional sales of new versions of EdenCrete® also expected. o Invitations to Bid (ITBs) issued for first 2 GDOT repair projects that in aggregate require over US $225,000 of EdenCrete®. o Latest GDOT estimate is for 22 repair projects before 30 June 2018.

•DETAILS
New Product Development Over the past six months Eden Innovations Limited (“Eden”) (ASX: EDE) has made significant progress in the development of two new versions of EdenCrete®: a high concentration, lower cost version (EdenCrete® HC), and a new version suitable for use in the widely used concrete made with pozzolanic cement (EdenCrete® P). 2 Each of the new versions is anticipated to attract considerable interest when released for commercial trials and sales, planned for early in the first quarter of 2018. These two additional products will be formally launched at World of Concrete 2018 in Las Vegas in January 2018, two years after EdenCrete® was formally launched at the same convention.

My take the wheels have not stopped turning, therefore patients will need to be upheld...